home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Targets & Cell Types in Immuno-Oncology Europe 2023

  August 08, 2023  
Oxford Global, Berlin, Germany

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells 


Expand your knowledge & discuss future priorities in:

  •  Emerging Technologies, Strategies & Methods for Novel Targets & Target Validation in Immuno-Oncology
  • Novel Cell Types to Develop Effective IO Therapies
View the agenda:https://www.oxfordglobal.co.uk/immuno-targets-cells/agenda/?utm_source=hummolgen&utm_medium=eventlisting&utm_campaign=immuno&utm_content=tacell2023
Co-located with Biomarkers Europe 2023 and Precision Oncology Europe 2023, attendees will receive access to all three events. For more information contact marketing@oxfordglobal.co.uk
Organized by: Oxford Global
Invited Speakers:

Meet key decision markers representing large pharma & biotech companies:

Kris Clark, Grey Wolf Therapeutics

Stefano Sammicheli, Ichnos Sciences

Jorg Rippmann, Boehringer Ingelheim

Gregory Vladimer, Exscientia

Nisit Khandelwal, iOmx Therapeutics

Cecile Bauche, Alaya.bio

& much more!

Deadline for Abstracts: 01/11/2023
Registration: https://www.oxfordglobal.co.uk/immuno-targets-cells/book-now/
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.